| Primary |
| Routine Health Maintenance |
100.0% |
|
|
| Secondary |
| Product Used For Unknown Indication |
59.8% |
| Drug Use For Unknown Indication |
25.4% |
| Constipation |
3.1% |
| Infection |
3.0% |
| Pyrexia |
2.7% |
| Dyschezia |
2.1% |
| Diuretic Therapy |
0.8% |
| Hyperemesis Gravidarum |
0.8% |
| Premedication |
0.8% |
| Intracranial Pressure Increased |
0.4% |
| Large Cell Lung Cancer Metastatic |
0.4% |
| Non-small Cell Lung Cancer |
0.3% |
| Brain Neoplasm |
0.1% |
| Hepatic Cirrhosis |
0.1% |
| Insomnia |
0.1% |
| Polyuria |
0.1% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
27.8% |
| Pancreatic Carcinoma |
24.1% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
9.3% |
| Headache |
5.6% |
| Toxic Epidermal Necrolysis |
5.6% |
| Abdominal Pain |
3.7% |
| Lymphocyte Stimulation Test Positive |
3.7% |
| Congenital Anomaly |
1.9% |
| Diarrhoea |
1.9% |
| Drug Hypersensitivity |
1.9% |
| Faecal Volume Increased |
1.9% |
| Faeces Discoloured |
1.9% |
| Ileus |
1.9% |
| Jaundice |
1.9% |
| Myasthenia Gravis |
1.9% |
| Renal Failure Acute |
1.9% |
| Syncope |
1.9% |
| Vomiting |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
43.8% |
| Drug Use For Unknown Indication |
17.8% |
| Constipation |
8.1% |
| Prophylaxis |
5.5% |
| Pain |
5.1% |
| Hypertension |
2.7% |
| Nausea |
2.4% |
| Maternal Exposure During Pregnancy |
1.5% |
| Ill-defined Disorder |
1.3% |
| Premedication |
1.3% |
| Infection Prophylaxis |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Insomnia |
1.1% |
| Dyspepsia |
1.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.1% |
| Osteoporosis |
1.0% |
| Antibiotic Prophylaxis |
1.0% |
| Gastrooesophageal Cancer |
1.0% |
| Parkinson's Disease |
0.9% |
| Mucosal Inflammation |
0.9% |
|
| Vomiting |
17.7% |
| Sepsis |
7.3% |
| Atrial Flutter |
6.5% |
| Thrombocytopenia |
6.5% |
| White Blood Cell Count Decreased |
6.5% |
| Platelet Count Decreased |
5.6% |
| Intestinal Perforation |
4.8% |
| Hepatitis |
4.0% |
| Pneumonia |
4.0% |
| Stevens-johnson Syndrome |
4.0% |
| Syncope |
4.0% |
| Hyperammonaemia |
3.2% |
| Ileus |
3.2% |
| Oral Mucosal Exfoliation |
3.2% |
| Pulmonary Embolism |
3.2% |
| Renal Failure |
3.2% |
| Renal Failure Acute |
3.2% |
| Shock |
3.2% |
| Somnolence |
3.2% |
| Staphylococcal Sepsis |
3.2% |
|
